The Invanz Spectrum

The Invanz Spectrum

The sixteen pathogens indicated for the broad spectrum antibiotic INVANZ™ for a global launch campaign by Merck Pharmaceuticals: Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides fragilis, Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Klebsiella pneumoniae, Streptococcus agalactiae, Porphyromonas asaccharolytica, Prevotella bivia and Biophilia wadsworthia.